Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque UCITS intelligence

Editorial

Tuesday, November 05, 2013

Why UCITS?

In the last four years so many panels, surveys, white papers covered this critical topic.

However, we continue to see fund managers launching UCITS vehicles to match investors' regulatory requirements. Recently, the English fund manager Finisterre Capital initiated a strong move by setting up an EU regulated fund after one of its insurance clients threatened to pull out its money from its offshore existing fund.

Those cases show that beyond disappointments on the restrictions imposed when managing UCITS vehicle, beyond the disappointment of the performance, beyond the rational offshore/onshore debate, here comes the fact: UCITS are for the moment, the only acceptable vehicle for many institutional investors in Europe.

According to our data partner Alix Capital, the number of funds is stagnating and the assets are growing. As Louis Zanolin explained, the assets continue to flow in big traditional brands with distribution networks and capacity. This phenomenon is not new and is reflecting the institutionalisation of the UCITS market. Small funds with assets under $15m close down.

Another critical fact is how the development of UCITS since 2008 has progressively impacted the business models of hedge funds. P. Schoenfeld Asset Management "PSAM" (see last edition) an event driven firm, has seen nearly doubled its UCITS assets year to date. That implies a different cultural mind set in terms of reporting, compliance, liquidity and risk management as well as the impact of the implementation of AIFMD.

I wish you a happy reading and take this opportunity to thank you for your great comments and support!

Sophie van Straelen

 

Sophie

About your editor: Sophie van Straelen and Asterias Ltd: Sophie van Straelen started her professional career in investment banking spanning derivative markets and hedge funds. Her 12 year experience in investment banking provided a strong base to found Asterias Ltd, the consultancy located in London, specialised in delivering strategic insight in distribution for service providers and hedge fund managers. Listed in 2009 by EFinancial News as one of the top 100 most influential women in finance in Europe, she is a recognized, valuable and independent source of analysis for the media, lobbying groups and investors.



 
This article was published in Opalesque UCITS intelligence.
Opalesque UCITS intelligence
Opalesque UCITS intelligence
Opalesque UCITS intelligence
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und